» Articles » PMID: 21675904

Multiple Myeloma

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2011 Jun 17
PMID 21675904
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma.

Pang Q, Wang Y, Bi D, Lu H Cancer Biol Ther. 2020; 21(11):1051-1059.

PMID: 33131397 PMC: 7678947. DOI: 10.1080/15384047.2020.1831373.


Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p.

Yang X, Huang H, Wang X, Liu H, Liu H, Lin Z Cancer Cell Int. 2020; 20:38.

PMID: 32025219 PMC: 6998159. DOI: 10.1186/s12935-020-1118-1.


Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study.

Wang J, Cao X, Zhao A, Cai H, Wang X, Li J Cancer Cell Int. 2018; 18:187.

PMID: 30479566 PMC: 6245875. DOI: 10.1186/s12935-018-0687-8.


Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.

Chen L, Hu N, Wang C, Zhao H, Gu Y Cell Cycle. 2017; 17(3):319-329.

PMID: 29228867 PMC: 5914888. DOI: 10.1080/15384101.2017.1407893.


[Molecular mechanisms and relationship of M2-polarized macrophages with early response in multiple myeloma].

Chen X, Sun R, Zhang W, Liu T, Zheng Y, Wu Y Zhonghua Xue Ye Xue Za Zhi. 2017; 38(6):480-486.

PMID: 28655090 PMC: 7342963. DOI: 10.3760/cma.j.issn.0253-2727.2017.06.004.